PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1084089
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1084089
Global Peripheral Stent Market is valued at approximately XX in 2021 and is anticipated to grow with a healthy growth rate of more than 5% over the forecast period 2022-2028. Peripheral stents are small tubular metal scaffolds that are inserted into the peripheral vessels to treat narrowing or blockage in arteries or veins, improving blood flow. Stents for the peripheral arteries are frequently used in conjunction with balloon angioplasty. During the pandemic, the number of surgical procedures for PAD patients is limited, and people's willingness to seek medical treatment changed as well. The number of PAD patients who underwent surgery was significantly lower than the previous year, but the severity of their limb ischemia was significantly higher, resulting in a higher rate of perioperative complications. The number of vascular surgeries has been significantly reduced during COVID-19, according to a study published in the Annals of Vascular Surgery in August 2020 titled "Impact of COVID-19 on Peripheral Arterial Disease Treatment". The peripheral stent market is expected to grow due to an increase in the prevalence of peripheral diseases, as well as the introduction of advanced devices. PAD affects both men and women, according to a report released by the Centers for Disease Control and Prevention in September 2021, but African Americans are at a higher risk of developing it. Hispanics may have similar to slightly higher rates of PAD than non-Hispanic white people. In the United States, approximately 6.5 million people aged 40 and up suffer from PAD. As a result, rising PAD prevalence is expected to increase demand for peripheral stents, boosting the market growth. However, the market may be restrained over the forecast period due to the stringent approval process for stents.
The key regions considered for the global Peripheral Stent market study include: Asia Pacific, North America, Europe, Latin America, and Rest of the World. Because of the rising burden of cardiac diseases and the ageing population, as well as product launches by key market players, North America is expected to hold a significant market share in the global peripheral stent market. However, Asia-Pacific is expected to have the highest CAGR due to an increase in the prevalence of coronary artery disease, the rise in the number of geriatric populations, growth in healthcare expenditures, and increased adoption of unhealthy lifestyles,
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
List of figures